- List
- By Topic
- On Map
- Search Details

"progressive external ophthalmoplegia" OR "CPEO" OR "PEO" OR "chronic progressive external ophthalmoplegia"
Need help? See RSS Feeds
Choose a feed type:

"progressive external ophthalmoplegia" OR "CPEO" OR "PEO" OR "chronic progressive external ophthalmoplegia" (205 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02161848 | Completed | MRI Study - Chronic Progressive External Ophthalmoplegia |
|
|
Observational |
|
Other |
|
|
133 | All | 18 Years to 80 Years (Adult, Senior) | NCT02161848 | H-3-2012-163 (CPEO) | CPEO | June 2014 | October 2015 | October 2015 | June 12, 2014 | April 14, 2016 |
|
||
2 | NCT02781493 | Not yet recruiting | Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
600 | All | 18 Years to 70 Years (Adult, Senior) | NCT02781493 | 2016SDU-QILU-06 | June 2016 | March 2017 | March 2017 | May 24, 2016 | May 27, 2016 |
|
||
3 | NCT02073552 | Completed | Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid. |
|
|
Interventional | Phase 4 |
|
Other |
|
|
472 | All | Child, Adult, Senior | NCT02073552 | REPREP1 2013-002506-31 |
REPREP1 | May 2014 | December 2015 | May 2016 | February 27, 2014 | June 27, 2016 |
|
|
4 | NCT02551198 | Unknown † | Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation |
|
|
Interventional | Phase 3 |
|
Other |
|
|
184 | All | 20 Years to 75 Years (Adult, Senior) | NCT02551198 | NCC2015-0210 | November 2015 | March 2016 | September 2016 | September 16, 2015 | November 30, 2015 |
|
||
5 | NCT01778192 | Completed | A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate |
|
|
Interventional | Phase 3 |
|
Other |
|
|
200 | All | 18 Years to 75 Years (Adult, Senior) | NCT01778192 | Korea University | July 2012 | November 2012 | December 2012 | January 29, 2013 | January 31, 2013 |
|
||
6 | NCT01929590 | Completed | Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy |
|
|
Interventional | Phase 3 |
|
Other |
|
|
180 | All | 18 Years to 80 Years (Adult, Senior) | NCT01929590 | end-407-11-11-1 | October 2011 | June 2012 | June 2012 | August 28, 2013 | August 28, 2013 |
|
||
7 | NCT03067675 | Active, not recruiting | Triton Reference Database |
|
|
Observational |
|
Industry |
|
|
500 | All | 18 Years and older (Adult, Senior) | NCT03067675 | Triton RDB | March 1, 2017 | August 30, 2017 | September 30, 2017 | March 1, 2017 | August 4, 2017 |
|
|||
8 | NCT01093274 | Unknown † | Efficacy and Safety of Polyethylene Glycol Compared With Sodium Picosulphate for Bowel Preparation Before Colonoscopy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
200 | All | 18 Years to 80 Years (Adult, Senior) | NCT01093274 | Gal001 | March 25, 2010 | March 25, 2010 |
|
|||||
9 | NCT03080714 | Active, not recruiting | Triton Agreement and Precision Study |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT03080714 | Triton AP | March 13, 2017 | August 30, 2017 | September 30, 2017 | March 15, 2017 | August 4, 2017 |
|
||
10 | NCT01320059 | Completed | Study of 18F-Fluoro-PEG6-IPQA |
|
|
Interventional | Phase 1 |
|
Other / U.S. Fed |
|
|
6 | All | 18 Years and older (Adult, Senior) | NCT01320059 | 2009-0832 W81XWH-05-2-0027 NCI-2014-01375 |
February 2012 | April 2016 | April 2016 | March 22, 2011 | June 27, 2016 |
|
||
11 | NCT01189409 | Suspended | Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients |
|
|
Interventional | Phase 4 |
|
Other |
|
|
64 | All | 18 Years and older (Adult, Senior) | NCT01189409 | H0901329 | June 2010 | July 2018 | July 2019 | August 26, 2010 | December 26, 2017 |
|
||
12 | NCT03107104 | Active, not recruiting | Triton Fundus Autofluorescence and Fluorescein Angiography |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT03107104 | Triton FA FAF | March 30, 2017 | August 30, 2017 | September 30, 2017 | April 11, 2017 | August 4, 2017 |
|
||
13 | NCT03011788 | Recruiting | Polyethylene Glycol Cleansing in Patients at High Risk for Poor Bowel Preparation |
|
|
Interventional | Not Applicable |
|
U.S. Fed |
|
|
270 | All | 18 Years and older (Adult, Senior) | NCT03011788 | AN0011 | January 2017 | January 2018 | June 2018 | January 5, 2017 | January 6, 2017 |
|
||
14 | NCT02956057 | Completed | Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
1044 | All | 18 Years and older (Adult, Senior) | NCT02956057 | BN102016 | November 2016 | May 2017 | August 2017 | November 4, 2016 | October 13, 2017 |
|
||
15 | NCT03022383 | Enrolling by invitation | TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
15 | All | 18 Years and older (Adult, Senior) | NCT03022383 | Topcon Triton 1222-2016 | January 2017 | February 2017 | January 16, 2017 | January 16, 2017 |
|
|||
16 | NCT00153114 | Completed | PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
100 | All | 4 Years to 16 Years (Child) | NCT00153114 | 851-15 | January 2003 | September 2004 | September 12, 2005 | February 7, 2013 |
|
|||
17 | NCT00828984 | Completed Has Results |
Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
87 | All | 18 Years and older (Adult, Senior) | NCT00828984 | NCI-2009-01113 NCI 06-8-01 CDR0000632553 N01CN35157 NCI06-8-01 NWU06-8-01 P30CA060553 |
October 2009 | October 2014 | October 2014 | January 26, 2009 | April 18, 2017 | January 19, 2017 |
|
|
18 | NCT02526823 | Recruiting | Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma |
|
|
Interventional | Phase 4 |
|
Other |
|
|
360 | All | 18 Years to 80 Years (Adult, Senior) | NCT02526823 | ShandongPH01 | August 2015 | August 2017 | February 2019 | August 18, 2015 | April 19, 2016 |
|
||
19 | NCT02981758 | Recruiting | Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT) |
|
Observational |
|
Other |
|
|
300 | Female | Child, Adult, Senior | NCT02981758 | Pro2016-0184 | ADOPT | July 2016 | July 2017 | July 2017 | December 5, 2016 | December 5, 2016 |
|
|||
20 | NCT03100513 | Recruiting | PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
100 | All | Child, Adult, Senior | NCT03100513 | Hanan Soliman | March 11, 2017 | October 2019 | December 2019 | April 4, 2017 | April 27, 2017 |
|
||
21 | NCT03356015 | Not yet recruiting | Comparison Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation |
|
|
Interventional | Phase 4 |
|
Other |
|
|
260 | All | 18 Years to 75 Years (Adult, Senior) | NCT03356015 | PEG-171116 | December 1, 2017 | January 1, 2018 | February 1, 2018 | November 29, 2017 | November 29, 2017 |
|
||
22 | NCT00153140 | Completed | Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
239 | All | 18 Years to 64 Years (Adult) | NCT00153140 | 851-ZCC | July 2004 | October 2004 | September 12, 2005 | February 7, 2013 |
|
|||
23 | NCT02657564 | Recruiting | Renal Safety of Bowel Preparation With Polyethylene Glycol |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1152 | All | 40 Years and older (Adult, Senior) | NCT02657564 | ZEH-2016-1 | January 2016 | June 2017 | June 2017 | January 18, 2016 | August 2, 2016 |
|
||
24 | NCT01923376 | Withdrawn | Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
0 | All | 18 Years to 80 Years (Adult, Senior) | NCT01923376 | 401550 | HELP | February 2013 | February 2014 | February 2014 | August 15, 2013 | May 12, 2015 |
|
|
25 | NCT02467790 | Unknown † | Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
24 | All | 31 Years to 65 Years (Adult) | NCT02467790 | PEX168-Ih | February 2015 | March 2016 | May 2016 | June 10, 2015 | January 26, 2016 |
|
||
26 | NCT02419534 | Unknown † | Pediatrics Anal Fissures Treatment With Polyethylene Glycol |
|
|
Interventional | Phase 4 |
|
Other |
|
|
46 | All | up to 13 Years (Child) | NCT02419534 | 14/4293 | November 2014 | November 2016 | November 2016 | April 17, 2015 | March 1, 2016 |
|
||
27 | NCT01626040 | Completed | Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children |
|
|
Observational |
|
Other |
|
|
178 | All | 1 Year to 18 Years (Child, Adult) | NCT01626040 | 12-008643 | June 2012 | January 2014 | January 2014 | June 22, 2012 | January 17, 2014 |
|
|||
28 | NCT01901510 | Completed | Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep |
|
|
Interventional | Phase 1 |
|
Other |
|
|
21 | All | 50 Years to 75 Years (Adult, Senior) | NCT01901510 | 12-009897 | May 2013 | July 2014 | July 2014 | July 17, 2013 | March 3, 2015 |
|
||
29 | NCT03410524 | Recruiting | Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy |
|
|
Interventional | Phase 3 |
|
Other |
|
|
250 | All | 18 Years to 80 Years (Adult, Senior) | NCT03410524 | 1139179 | January 9, 2018 | October 31, 2018 | December 31, 2018 | January 25, 2018 | January 25, 2018 |
|
||
30 | NCT00558376 | Terminated | Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
23 | All | 18 Years to 70 Years (Adult, Senior) | NCT00558376 | SHEBA-07-4884-SBH-CTIL | January 2008 | March 2009 | March 2009 | November 14, 2007 | May 5, 2009 |
|
||
31 | NCT03148002 | Recruiting | Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation |
|
|
Interventional | Phase 4 |
|
Other |
|
|
30 | All | Child, Adult, Senior | NCT03148002 | PDBowel2017 | July 7, 2017 | November 1, 2017 | February 1, 2018 | May 10, 2017 | July 19, 2017 |
|
||
32 | NCT03329339 | Completed | The Effect of 1L Polyethylene Glycol Plus Ascorbic Acid With Prepackaged Low-Residue Diet for Bowel Preparation |
|
|
Interventional | Not Applicable |
|
Other |
|
|
200 | All | 18 Years to 85 Years (Adult, Senior) | NCT03329339 | B-1505-297-003 | May 15, 2015 | December 31, 2016 | December 31, 2016 | November 6, 2017 | November 6, 2017 | |||
33 | NCT02396017 | Unknown † | Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT02396017 | SPLIT-PEG-CE | March 2015 | May 2015 | May 2015 | March 24, 2015 | March 24, 2015 |
|
||
34 | NCT02178033 | Unknown † | The Impact of Split Dose of Low-volume Polyethylene Glycol on Adenoma Detection Rate |
|
|
Interventional | Not Applicable |
|
Other |
|
|
514 | All | 50 Years to 69 Years (Adult, Senior) | NCT02178033 | Split dose-ADR | January 2014 | December 2014 | January 2015 | June 30, 2014 | June 30, 2014 |
|
||
35 | NCT00565669 | Completed | Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT00565669 | SEI-07-003 | October 2007 | October 2008 | October 2008 | November 30, 2007 | May 4, 2016 |
|
||
36 | NCT03448770 | Recruiting | To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
110 | All | 18 Years to 65 Years (Adult) | NCT03448770 | ILBS-cirrhosis-14 | August 1, 2017 | July 31, 2018 | July 31, 2018 | February 28, 2018 | February 28, 2018 |
|
||
37 | NCT00153153 | Completed | Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
300 | All | 18 Years and older (Adult, Senior) | NCT00153153 | 851-CR1 | August 2003 | December 2004 | September 12, 2005 | February 7, 2013 |
|
|||
38 | NCT02292459 | Withdrawn | Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT02292459 | 18128 CL2012-15 8114-005 |
December 2015 | December 2015 | December 2015 | November 17, 2014 | July 16, 2015 | |||
39 | NCT03060512 | Completed | To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation |
|
|
Interventional | Phase 4 |
|
Industry / Other |
|
|
273 | All | 18 Years to 84 Years (Adult, Senior) | NCT03060512 | D3820L00017 | March 2, 2017 | August 23, 2017 | August 23, 2017 | February 23, 2017 | September 8, 2017 |
|
||
40 | NCT01929668 | Completed | Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients |
|
|
Interventional | Not Applicable |
|
Other |
|
|
114 | All | 18 Years to 80 Years (Adult, Senior) | NCT01929668 | 2013-07-036-002 | 2SCANI | August 2013 | December 2014 | December 2014 | August 28, 2013 | April 28, 2016 |
|
|
41 | NCT01610895 | Unknown † | Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet |
|
|
Interventional | Not Applicable |
|
Other |
|
|
345 | All | 18 Years to 74 Years (Adult, Senior) | NCT01610895 | 24206 | BP | December 2011 | August 2012 | October 2012 | June 4, 2012 | June 4, 2012 |
|
|
42 | NCT01965496 | Completed | A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes |
|
|
Interventional | Phase 1 |
|
Industry / Other |
|
|
64 | All | 20 Years to 70 Years (Adult, Senior) | NCT01965496 | PEX168-I-05 | March 2012 | March 2013 | April 2013 | October 18, 2013 | October 18, 2013 |
|
||
43 | NCT01965509 | Completed | A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
120 | All | 20 Years to 70 Years (Adult, Senior) | NCT01965509 | PEX168-I-06 | May 2012 | August 2013 | October 2013 | October 18, 2013 | October 18, 2013 |
|
||
44 | NCT01589640 | Unknown † | Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance |
|
|
Observational |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT01589640 | EDD-BLNK-12-001 | May 2012 | September 2012 | October 2012 | May 2, 2012 | May 2, 2012 |
|
|||
45 | NCT01164410 | Completed | The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children |
|
Observational |
|
Other |
|
|
45 | All | 5 Years to 21 Years (Child, Adult) | NCT01164410 | CCF 09-378 | August 2009 | April 2010 | June 2010 | July 16, 2010 | October 24, 2017 |
|
||||
46 | NCT01610856 | Completed | Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
250 | All | 50 Years to 75 Years (Adult, Senior) | NCT01610856 | 21972 Ethics ID 21972 |
March 2010 | June 2010 | June 2010 | June 4, 2012 | June 4, 2012 |
|
||
47 | NCT02451527 | Completed | The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects |
|
|
Interventional | Phase 1 |
|
Other |
|
|
16 | Male | 18 Years to 45 Years (Adult) | NCT02451527 | 2013L02060 | May 2015 | September 2015 | July 2016 | May 22, 2015 | November 30, 2016 |
|
||
48 | NCT01707667 | Completed Has Results |
Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
13 | All | 18 Years to 75 Years (Adult, Senior) | NCT01707667 | SPD555-403 2012-002495-13 |
January 2013 | November 2013 | December 2013 | October 16, 2012 | October 22, 2014 | October 22, 2014 |
|
|
49 | NCT00153127 | Completed | Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
100 | All | 19 Years and older (Adult, Senior) | NCT00153127 | 851-17 | November 2001 | September 2004 | September 12, 2005 | February 7, 2013 |
|
|||
50 | NCT01976858 | Completed | A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes |
|
|
Interventional | Phase 1 |
|
Industry / Other |
|
|
50 | All | 20 Years to 65 Years (Adult) | NCT01976858 | PEX168-I-03 | June 2011 | September 2011 | December 2011 | November 6, 2013 | November 6, 2013 |
|
† Study has passed its completion date and status has not been verified in more than two years.